|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash segregated for regulatory purposes | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Total cash, cash equivalents and restricted cash | ||||||||||||||||||||
| Trading securities | ||||||||||||||||||||
| Available-for-sale securities | ||||||||||||||||||||
| Stock of regulatory agencies | ||||||||||||||||||||
| Loans held for sale, carried at fair value | ||||||||||||||||||||
| Loans held for sale, lower of cost or fair value | ||||||||||||||||||||
| Loans—net of allowance for credit losses of $347,375 as of June 30, 2026 and $290,049 as of June 30, 2025 | ||||||||||||||||||||
| Servicing rights, carried at fair value | ||||||||||||||||||||
| Securities borrowed | ||||||||||||||||||||
| Customer, broker-dealer and clearing receivables | ||||||||||||||||||||
| Goodwill and other intangible assets—net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Advances from the Federal Home Loan Bank | ||||||||||||||||||||
| Secured financings | ||||||||||||||||||||
| Borrowings, subordinated notes and debentures | ||||||||||||||||||||
| Securities loaned | ||||||||||||||||||||
| Customer, broker-dealer and clearing payables | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Common stock—$0.01 par value; $150,000,000 shares authorized, $71,939,630 shares issued and $56,734,049 shares outstanding as of June 30, 2026; $71,101,642 shares issued and $56,483,617 shares outstanding as of June 30, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss)—net of income tax | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost; $15,205,581 shares as of June 30, 2026 and $14,618,025 shares as of June 30, 2025 | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
Loading...
